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The EUWAB-project (European Union Welfare Effects of Agricultural Biotechnology) 
 
Since 1995, genetically modified organisms have been 
introduced commercially into US agriculture.  These 
innovations are developed and commercialised by a 
handful of vertically coordinated “life science” firms who 
have fundamentally altered the structure of the seed 
industry.  Enforcement of intellectual property rights for 
biological innovations has been the major incentive for 
a concentration tendency in the upstream sector.  Due 
to their monopoly power, these firms are capable of 
charging a “monopoly rent”, extracting a part of the 
total social welfare.  In the US, the first ex post welfare 
studies reveal that farmers and input suppliers are receiving the largest part of the benefits.  
However, up to now no parallel ex ante study has been published for the European Union.  
Hence, the EUWAB-project (European Union Welfare effects of Agricultural Biotechnology) 
aims at calculating the total benefits of selected AgBiotech innovations in the EU and their 
distribution among member countries, producers, processors, consumers, input suppliers and 
government.  This project (VIB/TA-OP/98-07) is financed by the VIB - Flanders 
Interuniversitary Institute for Biotechnology, in the framework of its Technology Assessment 
Programme.  VIB is an autonomous biotech research institute, founded in 1995 by the 
Government of Flanders.  It combines 9 university departments and 5 
associated laboratories. More than 750 researchers and technicians are 
active within various areas of biotech research.  VIB has three major 
objectives: to perform high quality research, to validate research results and 
technology and to stimulate a well-structured social dialogue on 
biotechnology.  Address: VIB vzw, Rijvisschestraat 120,    B-9052 Gent, 
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Abstract 
In this working paper we attempt to establish a general analytical framework for the 
calculation of the micro- and macroeconomic benefits and costs of biotechnology 
applications in EU agriculture.  Since these innovative applications are typically 
protected by intellectual property rights, standard welfare analyses will overestimate 
total benefits generated by these innovations.  On the other hand, this doesn’t mean 
that innovators are extracting all of the benefits.  A recent ex-post welfare analysis on 
US Bt-cotton shows that farmers have captured the largest share of benefits (Falck-
Zepeda, Traxler and Nelson, 1999).  Due to the importance of intellectual property 
rights and the consolidation of the agricultural input industry, the framework 
presented by Moschini and Lapan (1997) seems to be the most adequate model as it 
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Introduction 
Even the optimists among biotechnology proponents have been impressed by the 
extremely fast farm-level adoption of bioengineered crops in the United States (US).  
In 1999, just four years from commercial introduction, an estimated 40 % of the total 
US corn, soybean and cotton acreage were planted with herbicide- and insect-resistant 
bioengineered crops (Kalaitzandonakes, 1999).  According to Fetrow (1999), since its 
approval in the US in 1994, rBST (recombinant bovine somatotropin) has been 
rapidly adopted by the dairy industry.  Today, of the nearly 9 million dairy cows in 
the US approximately 30 % receive the product during a lactation. 
 
However, while the agricultural sector is still revelling in the success of these 
biotechnological innovations based on a single input trait, executives and 
stockholders believe that a real agricultural revolution is still to be expected with the 
introduction of stacked input traits, quality traits and combinations of these traits 
(Coaldrake and Thomas, 1999). 
 
These innovations are being developed and commercialised by a handful of vertically 
coordinated “life science” firms who have fundamentally altered the structure of the 
seed industry.  Using mergers, acquisitions and licensing agreements, they ally their 
financial, scientific and organisational strengths with the genetic resources of 
traditional seed companies. 
 
Enforcement of intellectual property rights (IPR) for biological innovations have been 
the major incentives for this concentration tendency in the upstream sector.  On the 
one hand, Schumpeter (1942) suggests that this monopolisation may increase long run   5
or dynamic, social welfare trough an increased rate of investment in research and 
development (R&D).  On the other hand, due to their monopoly power, these firms 
are capable to charge a monopoly rent, extracting a part of total static social welfare. 
 
Growing concern is being expressed about the idea of an input industry extracting all 
of the benefits generated by these innovations.  In the US, the extremely high 
adoption rates of the first generation of bioengineered crops reflect that farmers are 
clearly receiving some benefits.  Can this picture be extrapolated to the European 
Union (EU)?  Which economic framework is appropriate to answer this question ex-
ante?  Which economic actors have to be taken into account and how can the research 
field be outlined?  These are the central questions of this inception report. 
 
Agricultural Biotechnology 
Agricultural Biotechnology in the Literature 
According to Riley and Hoffman (1999), biotechnology can be defined as the use of 
biological organisms or processes in any technological application.  Genetic 
engineering can be thought of as a subset of biotechnology, describing a set of 
techniques for altering the properties of biological organisms.  Using genetic 
engineering techniques, individual genes can be transferred between organisms, or 
genes in an organism can be modified to create plants, animals, or microbes with 
improved traits for biotechnological applications.  Hence, in this and the following 
working papers the terms “biotech” or “biotechnology”, “genetically engineered” and 
“genetically modified” are used interchangeably. 
 
   6
Persley (1990) presents the major applications of agricultural biotechnology as a 
continuum of related technologies, requiring an increasing level of scientific 
knowledge, technical sophistication, financial support and time for success.  This 
“gradient” of biotechnologies is illustrated in Figure 1.  Primarily, this presentation 
emphasises the progressive and continuous nature of the biotechnologies.  The 
discoveries made in the simpler technologies (downwards) led to those made in the 
more complex ones, and usually the simpler technologies are required for the success 
of the more complex ones.  Secondly, the gradient nature of the biotechnologies also 
reflects the increasing need of basic scientific knowledge. 
 
Our research will be concentrated on the last four agricultural biotechnology 
applications and mainly on genetic engineering of plants as agricultural innovation.  
In the literature, two waves are distinguished in this innovation (Kalaitzandonakes, 
1999; Coaldrake and Thomas, 1999; Hillyer, 1999; Riley and Hoffman, 1999): 
1. The  first wave of biotechnology innovations is based on input traits or agronomic 
traits.  Insertion of a gene in the plant genome protects the plant against pests or 
herbicides.  Early commercial products include Bacillus thuringiensis (Bt) corn. 
These genetically altered hybrids contain a naturally occurring soil bacterium, Bt, 
that kills European corn borers.  Bacillus thuringiensis cotton protects the crop 
against tobacco budworm and bollworm.  To fight weeds, farmers have several 
genetically engineered options to choose from.  Roundup Ready ® (glyphosate-
tolerant) soybeans and corn, and LibertyLink ® (glufosinate ammonium) corn are 
some examples.  These crops are immune to the broad spectrum, but non-selective 
herbicides, such as Roundup ®, Touchdown ® and Liberty ®. When applied, the 
herbicide kills the weeds without harming the crop. In the case of cotton, farmers   7
can turn to BXN ® (Bromoxynil) or Roundup Ready ® herbicide-tolerant 
varieties. More herbicide-resistant crops are on the way. 
2. The  second wave of biotechnology is based on output traits or quality traits.  
Unlike input traits that are designed to protect and enhance yield, output traits 
promise to enhance the value of the crops from the farmer to the consumer.  For 
growing tailored traits, farmers can earn premiums on each kg.  Early efforts in 
valued-added crops have focused on enhancing the value of animal feed since 
livestock are the dominant users of feedgrains.  This has led to the development of 
high-oil corn and hybrids with increased levels of amino acids and starch, to name 
a few.  Other traits include low phytate corn, also known as high available 
phosphorus corn, that increases the digestibility of the phytate nutrient by swine 
and poultry.  As a result, less phosphorus is excreted in the manure, making it 
more environmentally friendly.  For soybeans, many of the tailored traits are being 
developed to produce healthier oils and soy foods. The most common speciality 
soybeans are high oleic, high sucrose, low saturate, low linolenic and low null 
(produces a less beany taste).  Work is also progressing to turn plants into 
factories, using bio-engineered crops for renewable energy sources and industrial 
uses. Genetic engineering may also help tailor plants into nutraceuticals, the 
blending of a regular food product with a health-enhancing attribute, like calcium-
enriched orange juice (Hillyer, 1999).  Finally, some see biotechnology as a way 
to use plants to produce vaccines and other important medicines, so-called 
“pharming” (Zilberman, Yarkin and Heiman, 1999). 
 
 
   8
However, the picture can be considerably complicated when we consider stacking
1 
options.  While stacked varieties combining agronomic traits will be commercialised 
in the near future, it is highly likely that quality traits will be combined with other 
quality traits and with agronomic traits (Coaldrake and Thomas, 1999). 
 
Zilberman, Yarkin and Heiman (1999) use a product-based economic classification of 
agricultural biotechnology (agbiotech) applications.  They consider agbiotech as an 
extension of traditional breeding techniques that increases precision (allowing for 
selection of individual traits) and versatility (permitting genes to be obtained from 
virtually any organism).  They distinguish four types of products, each with different 
technical and economic implications: 
1.  Supply enhancing products (first wave); 
2.  Pest control products (first wave); 
3.  Quality modifying biotechnology innovations (second wave); 
4.  New products, e.g. “pharming” (second wave). 
 
Thus, unless labelling techniques are applied to distinguish GMO and non-GMO 
products, the products issued from first wave agbiotech innovations are identical 
goods facing the same demand function.  On the other hand, second wave innovations 
generate products with new characteristics easily recognised and distinguished by 
customers.  In that case, the product faces a specific demand function with specific 
characteristics.  The application of labelling techniques results in a segmentation of 
the product market in two groups, GMO and non-GMO, each group characterised by 
a specific demand function. 
   9
Agricultural Biotechnology as a Technical Change 
To study the socio-economic impact of agbiotech innovations, we make abstraction of 
the intrinsic aspects of the technology itself by considering it as a technical change, 
i.e. a change in the production function.  The economic theory of technical change has 
been subject to numerous corrections, adaptations and refinements.  In the late fifties 
and early sixties, Griliches (1957; 1958; 1963; 1964) published a series of articles 
presenting a method of measuring the social returns of research costs of hybrid corn 
and related innovations (Griliches, 1957).  Until today, researchers studying the 
economics of technical change refer often to his economic framework. 
 
Most studies have relied on measuring changes in the economic surplus (consumer 
and producer surplus) evaluated in the agricultural product market.  The basic idea is 
that improved production techniques allow farmers to supply a larger amount of 
output for any given price level.  Let Q be total pre-innovation physical agricultural 
output produced by a farmer with the traditional technology, characterised by the 
production function Q = f(X1, X2, …, Xn) with X1, X2, …, Xn total physical input of 
production factors i = 1, 2, …, n.  When the farmer adopts the new technology, 
reflected by the production function Q = g(X1, X2, …, Xn), three scenarios are possible 
(Binswanger, 1974; Blackorby, Lovell and Thursby, 1976): 
1.  Hicks neutral (HN) technical change: output Q(X1, X2, …, Xn) increases without 
affecting the shares of physical input levels X1, X2, …, Xn (Hicks, 1932); 
2.  Input-saving technical change: output Q(X1, X2, …, Xn) increases while decreasing 
the share of physical input level of at least one factor XI; 
3.  Input-using technical change: output Q(X1, X2, …, Xn) increases while increasing 
the share of physical input level of at least one factor XI.   10
This increase of physical agricultural output results in a shift of the supply curve 
affecting producers’ and consumers’ welfare.  In most cases the innovation affects 
differently the inframarginal, “low average cost” producers, located towards the 
“bottom end”, i.e. near the vertical axis, of the supply curve, and the marginal, “high 
average cost” producers located at the “top end” of the supply curve.  This 
phenomenon gives rise to three types of supply shifts (Lindner and Jarrett, 1978): 
1.  Parallel supply shift: the cost structures for all producers are reduced with the 
same amount; 
2.  Divergent supply shift: the cost structures for all producers are proportionately 
reduced; 
3.  Convergent supply shift: the cost structures for all producers are 
disproportionately reduced as social elite groups, represented by inframarginal 
producers, control the innovation. 
 
These six specific assumptions have changed from study to study, summarised by 
Norton and Davis (1981), Huffman and Evenson (1993) and Alston, Norton and 
Pardey (1995). 
 
Agbiotech in a Historical Context of Agricultural Innovations 
In this section, we place agbiotech in a historical framework, based on the research of 
Mazoyer and Roudart (1997), to compare its intrinsic features with the major 
agricultural innovations which occurred in the European temperate regions. 
 
At the end of the Middle Ages, Europe had already known three agricultural 
revolutions: the Neolithic, Antic and Medieval revolutions.  These revolutions have   11
engendered three major farming systems: shifting cultivation systems based on 
temporary “slash and burn” cultivation, fallow systems based on light ox-drawn 
ploughs and fallow systems based on heavy ox-drawn ploughs.  From the sixteenth to 
the nineteenth century, most of the European regions were subjected to a new 
agricultural revolution, the first agricultural revolution of Modern Times. 
 
This revolution led to the apparition of new farming systems: fallow has been 
replaced by artificial pastureland with grasses like ray-grass or fodder leguminosae.  
In the new rotation systems, fodder grasses alternate continuously with food crops 
facilitating the development of cattle breeding which, in turn, provides manure and 
mechanical energy (animal traction).  Yields increase and the improvement of animal 
feeding and plant fertilisation stimulates animal and plant selection.  In short, the first 
agricultural revolution of Modern Times led to an important increase of agricultural 
output obtained by only a few investments and little supplemental labour, i.e. an 
increase in the labour productivity, represented by the marginal product of labour L: 
MPL = dQ/dL. 
 
The first agricultural revolution of Modern Times can be seen as an endogenous 
organisational innovation characterised by an important Hicks neutral component of 
technical change.  According to Lindner and Jarrett (1978), organisational innovations 
are mostly scale dependent and result in a convergent shift of the supply curve.  If low 
cost producers correspond to skilled managers, then they are located at the bottom end 
of the supply function.  To the extent that the benefits of organisational innovations 
are positively correlated with managerial ability, the reduction in average costs is   12
greater for such farmers relative to their “high cost” counterparts at the top end of the 
supply curve. 
 
These productivity gains have brought to an end the crisis of the fallow systems that 
broke out in the fourteenth century and extended up to the eighteenth century.  For the 
first time in history, a new agriculture appears, capable to produce a commercial 
surplus.  By providing the growing industry with raw materials, labour and food, this 
has played a central role in the first industrial revolution.  In exchange, this 
productive agriculture, consuming iron, tools, etc., has become an important outlet for 
industrial products.   
 
At the end of the nineteenth and in the beginning of the twentieth century, industry 
produces new means of transport and new agricultural equipment bringing agriculture 
to its first world crisis of overproduction in the years 1890.  The second agricultural 
revolution extends this first phase of mechanisation up to the twentieth century, 
hinging on the development of new agricultural production means issued from the 
second industrial revolution:  
•  motorization (explosion motors, …); 
•  big mechanisation (complex and powerful machines, …); 
•  “chemistralisation
2” (fertilisers, drugs, phyto-sanitary products, …); 
•  “biologisation” (selection and breeding, in vitro cultivation, biotechnology, …). 
 
Kershen (1999) proposes an analogous terminology distinguishing three eras: the era 
of physics (eighteenth and nineteenth centuries), chemistry (twentieth century) and 
biology (twenty-first century).  Note the strong complementarity that exists between   13
these scientific innovations.  In order to obtain important yield increases, only adding 
fertilisers can not do this; again selected plant varieties capable to absorb and make a 
profit out of the added inputs, should be available.  Besides the adaptation of the 
plants to the increased use of fertilisers, plant variety selection aims also at the 
adaptation of the plants to the use of new mechanical equipment and the enforcement 
of resistance against diseases and pests. 
 
Today, in the industrialised countries only 5 % of the total active population are 
sufficient to nourish, better than ever, the population.  We assist at an important 
substitution of labour by capital, coupled with an enormous increase of labour 
productivity.  Hence, the second agricultural revolution, characterised by strong 
labour-saving, capital-using and land-using components, has been even faster than 
the precedent agricultural revolutions.  This revolution is also unequal: among the 
mass of farms that existed in the beginning of the century, only a small minority has 
managed to cross all phases.  Certainly, big capitalistic farms using hired labour and 
capable to acquire the necessary capital have been in a privileged position, while the 
majority of the exploitations have encountered a crisis and have disappeared.  As 
suggested by Lindner and Jarrett (1978), these innovations are likely associated to a 
convergent shift of the supply curve.  Nevertheless, notwithstanding this evolution, the 
familyl farm remains the predominant production unit of the industrialised countries. 
 
The phases of motorization and mechanisation reveal themselves by surface increases 
of cultivated land or increases in herd size per unit labour leading to important labour 
productivity increases.  Conversely, agricultural innovations resulting from scientific 
progress in chemistry and biology engender increases of yields per unit land or per   14
animal affecting on-farm added value.  The latter two phases of the second 
agricultural revolution are characterised by input-using (fertilisers, more effective 
pesticides, …), input-saving (pesticides that substitute for other inputs, …) as well as 
Hicks-neutral components (more productive seed varieties).  Moreover, these 
innovations are likely to result in a divergent shift of the supply curve since they 
reduce proportionately the cost structures for all producers (Griliches, 1957; Lindner 
and Jarrett, 1978). 
 
Since the farms don’t have to produce their own inputs and equipment anymore, they 
abandon the former polyproduction systems for more specialised production systems, 
oriented towards a few cash crops.  The choice of these crops depends on the expected 
profits taken into account the biophysical and economical conditions of the region and 
the specific production conditions of the farm.  An extensive multi-regional agrarian 
system has been created, composed of specialised and complementary regional sub-
systems (pastureland regions, fruit regions, viticulture regions, meat or milk cattle 
breeding, …), providing one national or international market.  This system is inserted 
in an ensemble of upstream industries (mechanical, chemical, biological and 
biotechnological industries) providing inputs and downstream industries (storage, 
transformation and commercialisation). 
 
The new system is characterised by a strong horizontal labour division between the 
regional sub-systems and a strong vertical labour division between the upstream, the 
agricultural and the downstream sector.  Due to this strong labour division, 
development of new production factors (machines, fertilisers, pesticides, vaccines, 
animal feeding, genetically selected varieties and races, …) flows gradually from the   15
farm to the surrounding sectors.  These functions have been absorbed by a new group 
of intellectual workers in public or private centres of research, education and 
extension. 
 
What’s the place of agricultural biotechnology in this historical framework?  Some 
scientists believe that the unique features of these innovations will reshape agriculture 
as profoundly as any other past paradigm change (Zilberman, Yarkin and Heiman, 
1999).  Do we have to do with a third agricultural revolution?  Remember the two 
waves we distinguished in section 1.1.  The specific features of the first wave are 
entirely coherent within the paradigm of the second agricultural revolution.  The 
biologic innovations tend to substitute or complete the chemical innovations.   
Through multimarket exploitation, chemical companies develop biotechnology that 
increases dependence on chemicals, whereas nonchemical companies tend toward 
development of biotechnology that substitutes for chemicals (Just and Hueth, 1993).  
Hence, first wave agbiotech can be seen as a continuation of the second agricultural 
revolution model. 
 
By comparing first with second wave agbiotech, a new paradigm emerges.  Some 
executives believe that these innovations will improve profitability on the farm 
(Coaldrake and Thomas, 1999).  Improved quality traits and total new products 
(“pharming”) with a very high added value and oriented to specific niche markets 
could profoundly reshape the role of agriculture as a commercial sector.  Whether 
these elements would bring agriculture in a third agricultural revolution is not clear 
yet in this changing environment.  
   16
Intrinsic Features of Agbiotech as an Agricultural Innovation 
Despite the fact that first wave agbiotech is in line with the general philosophy of the 
second agricultural revolution, this innovation brings along some completely new 
features.  According to Lesser (1999), the 1980 date is pivotal in the US agricultural 
input industry as it marks some strengthening amendments to the US Plant Variety 
Protection Act.  At that time, a number of observers identified a direct causal 
relationship between the strengthening of intellectual property rights (IPRs), merger 
activity of the US seed industry and investments by private firms in plant 
biotechnology research (Moschini and Lapan, 1997; Lesser, 1999; Brennan, Pray and 
Courtmanche, 1999).   
 
One of the key differences in agbiotech from previous agricultural innovations is that 
the new innovations have intellectual property rights that produce private value that is 
more easily captured by the inventors of that intellectual property than was the case in 
the past.  Previously, the natural ability of crops and animals to reproduce meant that 
it was not possible to capture the intellectual property value of agricultural products.  
Therefore, to prevent under-investment in new agricultural technology, most genetic 
improvements were subsidised by the state or developed directly by state-funded 
research establishments.  This has changed with the advent of modern biotechnology.  
The proportion of the value of an agricultural good represented by intellectual 
property has risen accordingly (Kerr, Yampoin and Hobbs, 1999; Foltz, Barham and 
Kim, 1999).  Hence, once again in recent history an ancient function, namely genetic 
selection, flows from the farm to the upstream industry sector. 
   17
Privatisation of the Commons? 
The broad literature that exists on the changing structure of the seed industry reflects 
some increasing international concerns.  Firstly, some authors are concerned about the 
so-called “privatisation of the commons”.  The traditional research paradigm 
represents discoveries flowing linearly from basic science conducted in public 
institutions to applied research and commercialisation undertaken largely by private 
industry.  Recent US legislation aimed to promote economic growth through 
supporting research acknowledges the “blurring of lines” between public and private 
research activities (Rausser, 1999).  Moreover, the increased collaboration between 
private firms and US State Agricultural Experiment Stations (SAES) raises fears that 
the independence, objectivity and credibility of SAES and their scientists may be 
compromised.  Likewise, there is concern that public funds provided to these 
institutions will be expended for private gain (Holt and Bullock, 1999).  There is 
evidence that public-private ventures can foster socially beneficial research, but a 
strong public research sector will remain important, as it can allay concerns about 
industry’s role in R&D (Klotz-Ingram and Day-Rubenstein, 1999).  Moreover, the 
potential for market failure resulting from under-investment in research is another 
justification for public agricultural research (Sonka and Pueppke, 1999).   
 
Another wide-spread concern is the fear that the ability of companies to gain IPRs 
over what were formerly freely available community resources (seeds, plants and 
even micro-organisms) will have devastating effects on both human communities and 
the protection of biodiversity (Dawkins, Thom and Carr, 1995).  Conversely, 
innovation that took place in communities over centuries, or even innovation in plant 
varieties that takes place in the present in a communal fashion, is not eligible for   18
protection (Lehman, 1994).  The international concern has come to a climax with the 
introduction of so-called terminator genes imposing a “natural” barrier to the farmer’s 
ancient right to harvest and reuse a part of his seeds. 
 
A third concern is related to the relationship between the industrialised and the 
developing countries.  Patent protection often covers crops that are particularly 
important in developing countries such as cotton, sorghum, cassava, millet, banana 
and rye.  This “genetic colonialism” will ensure that the North can control and profit 
from their use and secure import monopolies by preventing local production (Meister 
and Mayer, 1995).  
 
A fourth well-known concern, often referred to by opponents of biotechnology, is the 
potential for too much monopoly power due to the increasing consolidation and 
concentration of the agricultural input market (Hayenga, 1999).  Brennan’s (1999) 
analysis of the impacts of this phenomenon reveals that new firm entry in the 
innovation market is starting to show evidence of decline.  Research output by firms 
not in the top four also appears to be falling, and gains to efficiency appear to be 
negatively related to firm size.  Investments and research output by the larger firms 
both appear to be increasing.  Specific concern has been expressed about the firm 
Monsanto as it has dominated US and world markets since the early stages of the 
plant biotechnology industry.  In the US, almost 90 % of the acreage planted with 
genetically engineered seed are using Monsanto Products (James, 1998). 
 
Some opponents claim that we don’t need biotechnology as only multinationals 
benefit.  On the other hand, Schumpeter (1942) suggests that monopolisation may   19
increase long run or dynamic, social welfare trough an increased rate of investment in 
research and development (R&D).  We’ve put together the two extreme positions in 
the current biotechnology “multinational debate”.  Is it really the case that 
multinationals are extracting all of the benefits generated by their products, or are 
there other agents who benefit too? 
 
General Analytical Framework 
Intellectual Property Rights and the Welfare Effects of Agbiotech 
In November 1997, Moschini & Lapan (ML) published the article “Intellectual 
Property Rights and the Welfare Effects of Agricultural R&D”.  In this article, ML 
argue that the conventional assumption of competitive pricing in the literature about 
the welfare effects of technological change cannot hold when new technologies are 
produced by private firms because such innovations are typically protected by IPRs.  
Conventional methods usually overestimate the welfare gains from agricultural 
innovations.  
 
ML bring along some new elements in the analytical framework of welfare economics 
summarised by Huffman and Evenson (1993) and Alston, Norton and Pardey (1995).  
They complete the framework by including the possibility that the innovation is 
protected by IPRs, typically like in agbiotech innovations.  Thus, the two interrelated 
factors that need to be considered in describing how the price for the new innovation 
is determined are (a) the previously existing market structure and (b) whether the 
innovation is drastic (leading to unconstrained monopoly price of the innovated input) 
or nondrastic (so that the monopolist’s pricing decision is constrained by the threat of 
competition).  So, the correct evaluation of the benefits from R&D aimed at   20
agriculture needs to account for the relevant institutional and industry structure 
responsible for the actual development of technological innovations.  Hence, the 
methodology presented in the ML-model will play a key role in our research as it is 
closely related to the central question of our research project.   
 
General Analytical Framework 
In Figure 2 we present the general analytical framework on which the simulation 
model and the case studies of the following working papers are based.  In the middle 
the multistage biotechnology diffusion chain is presented.  The arrows represent the 
influence of stages or agents on other stages or agents.  In the following sections, we 
discuss the specific role of each stage in the agbiotech diffusion process. 
 
Government represents the first stage in the agbiotech diffusion process as it can 
influence the structure of the national system of biotechnology innovation and the 
input industry. For this purpose, it has five policy instruments for influencing the 
penetration of agbiotech into the agbiotech diffusion chain: 
1. Research  expenditures; 
2.  Intellectual Property Rights (IPRs) legislation; 
3. Regulatory  approval; 
4. Trade; 
5. Labelling  policies. 
 
(1) By modifying the budget of the national (universities, institutes, …) and 
international agricultural research systems, government influences the share of public 
sector research, typically fundamental, basic research.  As the latter forms the basis   21
for the more applied R&D, in a second phase government influences also applied 
R&D, typically private sector research.  Using patent data Foltz, Barham and Kim 
(1999) show with an econometric model the importance of the US land grant 
university infrastructure, technology transfer offices and star scientists in the public 
sector production of agbiotech patents. 
 
(2) Between the two extremes of (I) a patent system where IPRs are not respected and 
patent owners sell seeds directly to growers and (II) a patent system where IPRs are 
respected and patent rights are sold, there exists a continuum of IPR regimes 
associated with specific social costs and benefits.  In this continuum, (III) a social 
optimum exists maximising the welfare of consumers and producers taking into 
account both production and research costs.  Zilberman and Yarkin (1999) compare 
these three IPR regimes and show that the adoption rates will be highest under the 
social optimum and lowest where IPR is not respected.   
 
When IPR is respected and the cost of modifying all varieties is low, adoption rates 
may be very high and introduction of biotechnology enables yield increases and 
maintains biodiversity.  On the other hand, when IPR is not respected and only one 
biotechnology-modified variety is available, biodiversity may decline because the 
acreage of the modified variety may increase, and it may lead to elimination of some 
of the traditional varieties.  Under the social optimum, if the industry is facing an 
elastic demand and output prices do not change, introduction of biotechnology may 
increase utilised land.  Land expansion is less likely under IPR, because the seller of 
the seed will capture much of the rent increases through the seed rent. Land expansion 
is even less likely when only one variety is modified because of inability to protect   22
IPR.  This is especially the case when the modified variety is the one that is suitable 
for higher quality land. When the demand for the final product in inelastic, output 
price and acreage may decline most with the high-yield variety .The smallest declines 
in both may be where only one variety is modified because IPR is not respected. In 
the case where output demand is inelastic, the social optimum will result in the largest 
gain for consumers and the largest reduction in pressure on the environment because 
it will require less land. 
 
Less studied but very important are the actual and potential roles of compulsory 
licensing as an instrument of intellectual property policy.  A compulsory licence is a 
property right provided to one or more agents by the licensing or patent authorities 
that allows the holder of the compulsory license to use, to infringe or to exploit the 
rights previously granted to someone else.  Thus, a compulsory licence is a specific 
form of relaxation of, or exemption to, a right previously granted.  A compulsory 
license may be granted subject to any number of terms, such as those that specify 
royalties or licence fees that must be paid to the holder of the original rights or terms 
that confer a reciprocal right or privilege on the original rights holder (Horbulyk, 
1999).  Horbulyk shows that in a sector like agbiotech industry where the R&D 
process is typically cumulative, provisions of compulsory licensing within a system of 
IPRs have a potential role in sustaining innovation and technological change in 
agriculture.  
 
(3) The use of biotechnology in agriculture poses possible risks to human, animal, and 
plant health and life, and to the environment.  These are grouped under the rubric of 
sanitary and phytosanitary (SPS) risks and regulations.  They fall under the SPS   23
Agreement administered by the World Trade Organization (WTO).  Risk analysis is 
the preferred international approach to managing SPS risks.  It has been defined as a 
three-stage process, including risk assessment, risk management, and risk 
communication.  Under the SPS Agreement, countries are encouraged in their 
regulatory programs to use international standards set by the International Office of 
Epizootics (OIE), Codex Alimentarius Commission (Codex), and International Plant 
Protection Convention (IPPC). Differences between countries in rates of and 
conditions on regulatory approval of agricultural biotechnologies result from different 
approaches to the factors included in risk analysis and the inclusion of different 
factors (Caswell, 1999).  The influence of regulatory approval on the development of 
the agbiotech industry is well known in the EU.  Due to its regulatory uncertainty, the 
European biotechnology industry has been quickly dominated by the US, 
independently of international differences in inherited resource endowments (Lavoie 
and Sheldon, 1999). 
 
(4) However, if there is no SPS risk involved, regulations related to agricultural 
biotechnology, other than those dealing with intellectual property rights issues, fall 
under the Technical Barriers to Trade (TBT) Agreement (Caswell, 1999). Under the 
General Agreement on Tariffs and Trade (GATT) administered by the World Trade 
Organisation (WTO), regulations imposed by governments which inhibit the free flow 
of international commerce are considered non-tariff barriers to trade. One of the 
responsibilities which has been mandated to the WTO is determining when non-tariff 
barriers to trade are legitimate and when they are being used capriciously to protect 
domestic vested interests.  A major international dispute is brewing over the issue of 
whether the regulatory regimes being put in place to govern GMOs of agricultural   24
significance are capricious barriers to trade. The current focal point of the dispute is 
the EU, but one suspects that many countries are watching the evolving situation 
closely to see what precedents arise (Perdikis, Kerr and Hobbs, 1999).    
     
(5) Labelling policies are the fifth alternative of governments to regulate diffusion of 
agbiotech innovations in the agbiotech technology diffusion chain.  The choice of 
labelling policy has an important impact on the initial direction and speed of 
development of markets for foods produced with the use of GMOs, if consumers care 
about this product attribute.  Labelling policy is particularly important if it is linked to 
regulatory approval and market access.  For example, a country or country-group may 
allow market access only if labelling is in place to protect the rights of consumers to 
know and to choose.  In the longer run, labelling policy will be important to the extent 
that consumers view the use of biotechnology as an important attribute to select for or 
against.  If they do not, then labelling policy is likely to atrophy.  The regulatory 
options available to governments for labelling of GMOs at retail include (Caswell, 
1999): 
1.  Allow no labelling regarding the use or nonuse of GMOs; 
2.  Require mandatory labelling of products that use GMOs; 
3.  Allow voluntary labelling of products that do or do not use GMOs; 
4. Allow voluntary labelling of products that do not use GMOs, with an 
accompanying disclaimer noting the government’s judgement about any 
differences (e.g. safety) between products that use and do not use GMOs. 
 
The European Union has pursued the second strategy, while the US has chosen and 
stuck with the fourth policy since its labelling decision for rBST use.  If these systems   25
are too costly or do not meet with consumer acceptance, the market will tend to move 
toward not differentiating products produced with biotechnology or towards a ban on 
products produced with or containing GMOs, as it is the case in the EU. 
 
Several other factors influence government policy decisions, like geography, history, 
religious and socio-cultural aspects (Zechendorf, 1998), political ideology and 
national and international institutional context (Bartholomew, 1997).   
 
National System of Biotechnology Innovation and Input Industry 
Bartholomew explores the relationship between national institutional context and the 
development of biotechnology in the United States, United Kingdom, Japan and 
Germany (Bartholomew, 1997).  He distinguishes eight particular features of national 
institutional context, which affect the stocks and flows of scientific knowledge: 
1.  Tradition of scientific education; 
2.  Patterns of basic research funding; 
3.  Linkages with foreign research institutions; 
4.  Degree of commercial orientation of academia; 
5. Labour  mobility; 
6.  Venture capital system; 
7.  National technology policy; 
8.  Technological accumulation in related industrial sectors. 
He also considers three R&D practices at the level of the firm: 
1.  Collaboration with research institutions; 
2.  Interfirm R&D cooperation; 
3.  Utilisation of foreign technology.   26
Bartholomew concludes that national patterns in biotechnology R&D are linked to the 
configuration of country-specific institutional features into a national system of 
biotechnology innovation which supports (or impedes) the accumulation and diffusion 
of knowledge between the scientific and industrial communities.  Building on his 
comparative analysis, he argues that the particular characteristics of national systems 
of biotechnology innovation form the basis for complex interdependence within the 
global system. 
According to Zilberman, Yarkin and Heiman (1999), three economic agents 
determine the outcomes of biotechnology discoveries in the national system of 
biotechnology innovation:  
1.  Universities (U in Figure 2) which conduct research that leads to important 
discoveries; 
2.  Small biotechnology firms (B) made up of researchers and supported by venture 
capitalists, which tend to concentrate on developing biotechnology products, often 
combining efforts and resources through alliances with pharmaceuticals, other 
biotechnology forms and academic researchers; 
3. Large companies (M) which, in addition to internal R&D capabilities and 
alliances with biotechnology firms, have strong marketing networks in place and 
enough financial resources to bear the costs of product registration. 
 
Barker (1999) completes the picture by adding a fourth agent: international 
agricultural research centres (IARC).  IARCs were created with financial and 
technical support from the industrialised countries to help develop and disseminate 
new technology, largely because earlier efforts at direct technology transfer had 
failed.  The broad literature that exists on the changing structure of the agbiotech   27
industry shows how these four agents are interlaced.  The structure, conduct and 
performance of this system are important for agriculture as it influences the 
technology price and thus the rate of agbiotech innovation adoption.  This is the major 
contribution of the ML-model upon which our analyses will be based.  
 
Agrarian System 
Agbiotech innovations have an important impact on the farming system: production 
techniques, inputs and management are modified.  These changes bring about 
important micro-economic benefits and costs at the farm level.  Since commercial 
introduction of the first agbiotech innovations in 1995 in the US, the first ex-post 
studies calculating on-farm profits become available (Marra, Carlson and Hubbell, 
1998; Culpepper and York, 1998; Roberts, Pendergrass and Hayes, 1998; Fernandez-
Cornejo, Klotz-Ingram and Jans, 1999; Gianessi and Carpenter, 1999; McBride and 
Books, 1999; Butler, 1999; Fulton and Keyowski, 1999; Fetrow, 1999).  For rBST 
only, although more than 1.500 articles have been written on the ex-ante adoption of 
this agbiotech innovation (Centner and Lathrop, 1996), very few ex-post studies have 
been carried out (Butler, 1999).  Some authors report on studies carried out on rBST 
use in New York dairies (Lyson, Tauer and Welsh, 1995; Tauer and Knoblauch, 1997; 
Lesser, Bernard and Billah, 1999). 
 
Other interesting farm-level features, less studied, are the impact of agbiotech 
innovations on specialisation and diversification patterns, farm size and the 
introduction of contract production.  The introduction of rBST in the case of a milk 
quota, for instance, can generate a phenomenon of diversification, as a part of the   28
acreage becomes superfluous due to the milk yield increase.  This part can be used for 
another agricultural activity, like meat production.  
 
At a higher level, that of the agrarian system, literature offers very little analyses of 
the impacts of agbiotech innovations.  The analysis of regional specialisation, 
differentiated adoption rates among different classes of farmers (Fulton and 
Keyowski, 1999), inter-farm relations, vertical integration and sociological aspects 
could fulfil this need.  Finally, represented by their farmer organisations, farmers can 




First wave agbiotech innovations result essentially in a reduction of the production 
costs at the farm level.  According to Freebairn, Davis and Edwards (1982), in a 
multistage production system, the reduction at one stage provides benefits to 
producers at all stages to consumers (Alston and Scobie, 1982).  Hence, benefits, 
measured as changes in economic surplus flow from the farm sector, through the 
marketing sector, to the consumers. 
 
The application of labelling techniques and the introduction of second wave agbiotech 
products complicate the picture as they generate market segmentation, new niche 
markets and cost reductions for the marketing sector (e.g. in the case of delayed 
ripening tomatoes). 
   29
Agricultural Market 
Remember that we concluded the first part of our paper with the question “Is it really 
the case that multinationals are extracting all of the benefits generated by their 
products, or are there other agents who benefit too?”  This will be the central question 
of the macro-economic welfare analysis and the simulation model which will be 
developed in the following working papers.  We showed already the fitness of the 
ML-model to answer this question.  While most of the economic agbiotech literature 
deals with the transforming agbiotech input industry and the calculation of the internal 
rate of investment of agbiotech research, very few studies analyse the welfare effects 
on different groups of the agricultural production chain.  However, the first ex-post 
welfare analyses, carried out in the US, contain already convincing results (Falck-
Zepeda, Traxler and Nelson, 1999).  Falck-Zepeda, Traxler and Nelson show that 
even taken into account the IPR protection of Bt cotton, US farmers receive the 
largest single share of benefits, ranging from 42 % to 59 % of total surplus, while the 
combined share of the innovators, Monsanto and the seed firms, range from 26 % to 
44 %.  US consumers captured between 7 % and 9 % and the rest of the world 
obtained a net surplus ranging from 5 to 6 % of total surplus.  
 
The main conclusion of their study is that even under monopoly conditions, the 
innovator is only able to extract a portion of the surplus that it creates.  The 
monopolist must provide farmers with an adoption incentive by setting a price that 
makes the new input more profitable than existing options.  This principle is well 
established in the adoption literature (Griliches, 1957). 
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In industrialised
1 countries, characterised by an inelastic demand and an elastic 
supply, typically consumers capture the largest share of the total benefits of an 
agricultural innovation.  Cochrane (1958) depicted farmers as victims of technological 
change.  In his analysis, only the earliest adopters could benefit from new technology, 
and their benefits were fleeting.  Eventually, the price-depressing effects of increased 
output would offset the gains.  Those who were slow to adopt or did not adopt would 
lose.  He characterised the process as a “treadmill” that farmers must tread to survive 
but that involved unhappy consequences for agriculture.  Hence, the analysis of Falck-
Zepeda, Traxler and Nelson (1999) is a typical reflection of the adoption phase.  In a 
second phase, consumer surplus is expected to increase as agricultural output prices 
drop due to the increasing technology adoption and agricultural production. 
 
Consumers 
While consumer acceptance and consumption risks are widespread subjects of 
analysis (Kalaitzandonakes, 1998; Caulder, 1998; Marshall, 1998; Loader and 
Henson, 1998; Phillips and Isaac, 1998; Chess, 1998; Miller, 1998; Zechendorf, 1998; 
Hoban, 1998; Isaac and Phillips, 1999; Zepeda, Douthitt and You, 1999; 
Kalaitzandonakes and Marks, 1999; Kershen, 1999; Perdikis, Kerr and Hobbs, 1999; 
Miller, 1998), few literature exists on the real or potential welfare effects, due to a 
change in consumer surplus (CS).  
 
Consumer organisations lobbying for a moratorium (fat arrow in Figure 2) on the 
import of GMOs are very active in the EU.  Under the General Agreement on Tariffs 
                                                 
1 The opposite effect can be observed in developing countries.  Farmers, facing an elastic demand and 
an inelastic supply, typically capture the largest share of the total benefits of an agricultural innovation.   31
and Trade (GATT) administered by the World Trade Organisation (WTO) no 
regulations are provided for consumer concerns as a legitimate reason for countries to 
apply trade measures.  An analysis of Perdikis, Kerr and Hobbs (1999) shows the 
need for the inclusion of Trade Related Aspects of Consumer Concerns (TRACC). 
 
Environment 
Often-used arguments by biotechnology opponents are the potential long-term risks 
and biosafety aspects of releasing GMOs in the environment (Lehman, 1994; Van 
Dusen, 1999).  Another wide-spread concern is the loss of biodiversity due to massive 
introduction of IPR protected GMOs (Dawkins, Thom and Carr, 1995; Dawkins, 
1995). 
 
While the authors of micro-economic impact studies, referred to in section 2.2.3, also 
calculate pesticide level reduction, only a few studies calculate overall risks, costs and 
benefits associated with the introduction of genetically engineered varieties in the 
environment (Wesseler, 1999; Sianesi, 1999; Hurley, Secchi and Hellmich, 1999).  
What is often neglected in the arguments of opponents is the fact that a decision to 
delay or reject a release of a GMO avoids those risks, but forgoes also the potential 
benefits of an immediate release.  The benefits foregone have to be considered as a 
cost.   
 
Even a decision which is based on the assumption that the risk cannot be estimated 
and therefore transgenic crops should not be released implicitly assumes that the 
expected risks are higher than the expected benefits (Wesseler, 1999).  Via a real 
options approach, Wesseler brings about an important new element.  He shows that   32
traditional cost-benefit-analysis could result in socially non-optimal allocation of 
resources because the value of delaying a decision and waiting for additional 
information is neglected (“quasi-option value”). 
 
Delimitation of the Research Field 
After this extensive review of the existing literature, we can define the research field 
of the EUWAB-project (European Union Welfare effects of Agricultural 
Biotechnology) in four dimensions: 
1.  Geographic dimension: the European Union; 
2. Time  dimension:  ex-ante evaluation of the possible future economic impacts of 
biotechnology applications in agriculture; 
3.  Vertical dimension (the stages of the innovation diffusion chain that have to be 
taken into account): government, national system of biotechnology innovation and 
input industry insofar as they influence input price, farmers, agricultural market, 
consumers and the environment;  
4. Horizontal dimension: determination of product-specific case studies.  The 
simulation model has to be sufficiently general to take into account a number of 
agbiotech innovations.  After the completion of this model, case studies will be 
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Conclusions 
Agricultural biotechnology applications can be categorised in two waves: input traits 
and output traits.  Second wave agricultural biotechnology applications are coherent 
within the paradigm of the second agricultural revolution of Modern Times. 
 
Despite this fact, these innovations bring along some important new features.  Since 
agricultural biotechnology applications are typically protected by intellectual property 
rights, standard welfare analyses will overestimate total benefits generated by these 
innovations.  On the other hand, this doesn’t mean that biotechnology companies are 
extracting all of the benefits.  A recent ex-post welfare analysis on US Bt-cotton 
shows that farmers have captured the largest share of benefits (Falck-Zepeda, Traxler 
and Nelson, 1999).  Due to the importance of intellectual property rights and the 
increasing concentration of the agricultural input industry, the framework presented 
by Moschini and Lapan (1997) seems to be the most adequate model as it takes into 
account these elements. 
 
Furthermore, this model needs to be completed with analyses that take into account 
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1 Gene stacking involves combining traits (e.g. herbicide tolerance and insect resistance) in seed 
(Anonymous, 1999). 
2 literally translated from the French term “chimisation” used by Mazoyer and Roudart (1997)   48
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